Latest filing published 04 Jan 2023 for ImmunoPrecise Antibodies Ltd., €67k.
Gregory Stuart Smith is a declared insider of ImmunoPrecise Antibodies Ltd., with filings sourced from SEDI. Over a trading history stretching from 23 November 2020 to 3 January 2023, the count stands at 7 filings.
Every open-market trade on record is a purchase: 3 purchases worth €47k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 option exercises.
The median purchase comes to €14k.
The record was last updated on 4 January 2023 with an option exercise (€67k) in ImmunoPrecise Antibodies Ltd. The latest purchase dates back some time: it was published 1,495 days ago, on 23 September 2022. Filings reach the SEDI feed a median of 1 day after the trade. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations